Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.45%
#2 Venom Venom +23.49%
#3 Decred Decred +10.61%
#4 Wibx Wibx +8.05%
#5 Status Status +7.45%
#6 SkyAI SkyAI +7.31%
#7 aelf aelf +6.44%
#8 MarsCoin MarsCoin +5.78%
#9 Audiera Audiera +5.39%
#10 TRIA TRIA +4.71%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
설정
언어
한국어
통화
USD
테마
Finch Therapeutics Group, Inc. Finch Therapeutics Group, Inc.

Finch Therapeutics Group, Inc.

FNCH
주식 순위 #30545
Finch Therapeutics is a microbiome technology company with a portfolio of... Finch Therapeutics is a microbiome technology company with a portfolio of intellectual property and microbiome assets. The company is now focused on realizing the value of its intellectual property estate and other assets, while supporting the advancement of its microbiome technology through partnerships and collaborations after winding down development efforts.
주가
$10.20
마지막 동기화: 2026-08-05
시가총액
$16.38M
변동 (1일)
2.00%
변동 (1년)
-18.40%
국가
US
거래 Finch Therapeutics Group, Inc. (FNCH)

카테고리

Healthcare
Finch Therapeutics Group, Inc. (FNCH)의 EPS
2026 기준 EPS TTM: 0
Finch Therapeutics Group, Inc.의 최신 재무 보고서와 주가에 따르면, 현재 EPS (TTM)는 0입니다. 2026년 말에는 회사의 EPS가 0였으며, 이는 2026년의 EPS 0와 동일입니다.
Finch Therapeutics Group, Inc.의 EPS 기록 (2026 ~ 2026)
매년 말의 EPS
연도 EPS 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 EPS
회사 EPS EPS 차이 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $2.98 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $13.70 -
BE